Join to View Full Profile
988102 Nebraska Medical CtrOmaha, NE 68198
Phone+1 402-559-9800
Fax+1 402-559-4835
Dr. Armitage is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Iowa Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 1976 - 1977- University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1975 - 1976
University of Nebraska Medical Center College of MedicineResidency, Internal Medicine, 1973 - 1975
University of Nebraska College of MedicineClass of 1973
Certifications & Licensure
NE State Medical License 1973 - 2026
IA State Medical License 1975 - 2000
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FASCO) American Society of Clinical Oncologists, 2007
Publications & Presentations
PubMed
- Academic and community cancer center collaboration in acute myeloid leukemia: a road map to optimize care delivery.Prajwal Dhakal, James O Armitage, Vijaya Raj Bhatt
Leukemia & Lymphoma. 2025-04-01 - CLO25-054: Long Term Follow Up of Patients Undergoing High Dose Chemotherapy and Autologous or Allogeneic Stem Cell Transplantation for Mantle Cell Lymphoma.Sandra Amponsah Frimpong, Valerie Shostrom, Robert Gregory Bociek, Matthew Lunning, Christopher D'Angelo
Journal of the National Comprehensive Cancer Network. 2025-03-28 - Circulating Tumor DNA as Measurable Residual Disease in Aggressive B-Cell Lymphoma: A Narrative Review.Mark Roschewski, Dan L Longo, James O Armitage
JAMA Oncology. 2025-02-06
Journal Articles
- Do You Know TAFRO?James O Armitage, Matthew A Lunning, Blood
Abstracts/Posters
- The Effect of Age and CD34+ Stem Cell Dose on Autologous Hematopoietic Stem Cell Transplantation Outcomes in Multiple Myeloma _ Single Institution ExperienceJames O. Armitage, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Integrating Geriatric Assessment and Genetic Profiling to Personalize Therapy Selection in Older Adults with Acute Myeloid Leukemia (AML)James O. Armitage, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Effect of Using Multiagent Versus Single Agent Chemotherapy on Overall Survival (OS) of Older Adults with Acute Myeloid Leukemia (AML)James O. Armitage, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
Nivolumab Appears to Boost Cure Rate in Advanced Hodgkin LymphomaNovember 14th, 2024- Immunotherapy Improves Survival in People with Advanced Hodgkin Lymphoma, Study ShowsOctober 16th, 2024
- Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin’s LymphomaOctober 16th, 2024
- Join now to see all
Committees
- Co-chair, 2015 Update Committee, American Society of Clinical Oncology (ASCO) 2015 - Present
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
